Neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) are two distinct autoimmune central nervous system diseases, with overlapping clinical and radiological features but different pathophysiology and antibody profiles [1, 2]. This evidence concerns the gene MOG and neuromyelitis optica.